Histological Remission Leads to Less Endoscopic Flare-up in Moderate-to-Severe, Biologics Experienced Ulcerative Colitis Patients: A Comprehensive Retrospective Cohort Study

被引：0
|
作者：
Wei, Z. H. [1 ]
Le, P. H. [2 ,3 ,4 ]
Chiu, H. Y. [1 ]
Yeh, P. J. [3 ,5 ]
Chiu, C. T. [2 ,3 ,4 ]
Chiu, C. H. [3 ,6 ]
机构：
[1] Chang Gung Univ, Sch Med, Taoyuan, Taiwan
[2] Chang Gung Mem Hosp, Linkou Branch, Dept Gastroenterol & Hepatol, Taoyuan, Taiwan
[3] Chang Gung Mem Hosp, Chang Gung Microbiota Therapy Ctr, Taoyuan, Taiwan
[4] Taiwan Assoc Study Small Intestinal Dis, Taoyuan, Taiwan
[5] Chang Gung Mem Hosp, Div Pediat Gastroenterol, Linkou Branch, Dept Pediat, Taoyuan, Taiwan
[6] Chang Gung Mem Hosp, Div Pediat Infect Dis, Linkou Branch, Dept Pediat, Taoyuan, Taiwan
来源：
JOURNAL OF CROHNS & COLITIS | 2024年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P577
引用
收藏
页码：I1119 / I1121
页数：3
相关论文
共 28 条
  • [1] Histological remission in patients with moderate-to-severe ulcerative colitis undergoing biological therapy: a single-centre experience
    Di Ruscio, M.
    Variola, A.
    Geccherle, A.
    Lunardi, G.
    Castelli, P.
    Zamboni, G.
    Riddell, R.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S441 - S442
  • [2] Intestinal Ultrasound Is Accurate to Determine Endoscopic Response and Remission in Patients With Moderate to Severe Ulcerative Colitis: A Longitudinal Prospective Cohort Study
    de Voogd, Floris
    van Wassenaer, Elsa A.
    Mookhoek, Aart
    Bots, Steven
    van Gennep, Sara
    Lowenberg, Mark
    D'Haens, Geert R.
    Gecse, Krisztina B.
    GASTROENTEROLOGY, 2022, 163 (06) : 1569 - 1581
  • [3] TRANSCRIPTOMIC SIGNATURE OF RESPONSE TO VEDOLIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: RESULTS FROM AN INTERNATIONAL, MULTICENTER, RETROSPECTIVE COHORT STUDY
    Linggi, Bryan
    Salas, Azucena
    Veny, Marisol
    Borowski, Krzysztof
    Silverberg, Mark S.
    Milgrom, Raquel
    Stempak, Joanne
    Boland, Brigid
    Eckmann, Lars
    Smith, Michelle I.
    Parker, Claire E.
    Jairath, Vipul
    Teft, Wendy
    Vande Casteele, Niels
    GASTROENTEROLOGY, 2024, 166 (05) : S1114 - S1114
  • [4] Transcriptomic signature of response to vedolizumab in patients with moderate-to-severe ulcerative colitis: Results from an international, multicentre, retrospective cohort study
    Linggi, B.
    Salas, A.
    Veny, M.
    Borowski, K.
    Silverberg, M. S.
    Milgrom, R.
    Stempak, J.
    Boland, B.
    Eckmann, L.
    Smith, M. I.
    Parker, C. E.
    Jairath, V.
    Teft, W.
    Vande Casteele, N.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I71 - I71
  • [5] Fecal calprotectin as a predictor of histological remission in patients with ulcerative colitis treated with vedolizumab: A retrospective cohort study
    Rubtsov, D.
    Ramaswamy, P. Kakkadasam
    Mohsen, W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 104 - 104
  • [6] Efficacy and safety of tofacitinib in patients with moderate-to-severe ulcerative colitis: A real-world retrospective study
    Yoshimura, N.
    Okano, Soh
    Sako, Minako
    Takazoe, Masakazu
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S545 - S545
  • [7] Long-Term Effectiveness and Safety of Ustekinumab Dose Escalation in Patients with Moderate-to-Severe Ulcerative Colitis: A Multicenter Retrospective Cohort Study
    van Lierop, Lisa M. A.
    Albino, Larissa
    Rosentreter, Ryan
    Thomas, Pepijn W. A.
    Lu, Cathy
    Siffledeen, Jesse
    Kroeker, Karen I.
    Ma, Christopher
    Peerani, Farhad
    Halloran, Brendan P.
    Baumgart, Daniel C.
    Dieleman, Levinus A.
    Du, Lillian
    Hoentjen, Frank
    Wong, Karen
    DIGESTIVE DISEASES AND SCIENCES, 2025,
  • [8] Effectiveness and safety of vedolizumab and infliximab in biologic-naïve patients with moderate-to-severe ulcerative colitis: A multicenter, retrospective cohort study
    Meng, Rui Ping
    Huang, Bao Bao
    Wei, Yan Ling
    Lyu, Lin
    Yang, Huan
    Liu, Cheng
    Zhou, Hong Li
    Liao, Xi Ping
    Zhou, Jian Yun
    Xie, Xia
    JOURNAL OF DIGESTIVE DISEASES, 2024, 25 (04) : 230 - 237
  • [9] Comparative efficacy of vedolizumab and infliximab in patients with moderate-to-severe ulcerative colitis: a multicenter real world cohort study
    Sun, Y.
    Yang, H.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1555 - i1555
  • [10] COST PER RESPONSE/REMISSION ACROSS BIOLOGICS FOR THE TREATMENT OF BIOLOGIC NAIVE PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS FROM THE ITALIAN HEALTHCARE PROVIDER PERSPECTIVE
    Zouraq, Azzabi, I
    Fioravanti, L.
    Vernia, M.
    VALUE IN HEALTH, 2016, 19 (07) : A512 - A512
123